Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 15 January 2009, doi:10.1136/bmj.a2812
Cite this as: BMJ 2009;338:a2812
Clare F Heal, senior lecturer1, Petra G Buettner, senior lecturer2, Robert Cruickshank, general practitioner3, David Graham, general practitioner3, Sheldon Browning, general practitioner4, Jayne Pendergast, practice nurse3, Herwig Drobetz, staff orthopaedic surgeon5, Robert Gluer, medical student1, Carl Lisec, surgical registrar6
1 James Cook University, School of Medicine, Mackay Base Hospital, Queensland 4740, Australia, 2 James Cook University, Queensland 4811, 3 Walkerston Medical Centre, Mackay, Queensland 4740, 4 Molescan, Mackay, Queensland 4740, 5 Mackay Base Hospital, Queensland 4740, 6 Townsville General Hospital, Queensland 4740
Correspondence to: C F Heal clare.heal{at}jcu.edu.au
Design Prospective randomised placebo controlled double blind multicentre trial.
Setting Primary care in a regional centre in Queensland, Australia.
Participants 972 minor surgery patients.
Interventions A single topical dose of chloramphenicol (n=488) or paraffin ointment (n=484; placebo).
Main outcome measure Incidence of infection.
Results The incidence of infection in the chloramphenicol group (6.6%; 95% confidence interval 4.9 to 8.8) was significantly lower than that in the control group (11.0%; 7.9 to 15.1) (P=0.010). The absolute reduction in infection rate was 4.4%, the relative reduction was 40%, and the relative risk of wound infection in the control group was 1.7 (95% confidence interval 1.1 to 2.5) times higher than in the intervention group. The number needed to treat was 22.8.
Conclusion Application of a single dose of topical chloramphenicol to high risk sutured wounds after minor surgery produces a moderate absolute reduction in infection rate that is statistically but not clinically significant.
Trial registration Current Controlled Trials ISRCTN73223053 [controlled-trials.com] .
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?
Read all Rapid Responses